Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms

This publication has 53 references indexed in Scilit:

• VEGF-A splicing: the key to anti-angiogenic therapeutics?
  Nature Reviews Cancer, 2008
• The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
  British Journal of Cancer, 2008
• VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
  British Journal of Cancer, 2008
• An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform
  Nucleic Acids Research, 2008
• Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
  British Journal of Cancer, 2007
• Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
  Proceedings of the National Academy of Sciences, 2006
• Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT
  Nature Structural & Molecular Biology, 2005
• Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks
  Journal of Biological Chemistry, 2004
• The Hallmarks of Cancer
  Cell, 2000
• A serine kinase regulates intracellular localization of splicing factors in the cell cycle
  Nature, 1994